What HCPs want from digital pharma in 2026: The value gap
February 16, 2026 | HCP Digital Engagement, HCP experience, Healthcare Digital Experience, Life Sciences Innovation, Pharma Digital Strategy
We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.
In The value gap: What HCPs want from digital pharma in 2026, we uncover the three dimensions of value that now define meaningful digital engagement: Relevance, Utility and Usability.
Digital is no longer an emerging channel. It is a primary interface between pharma and HCPs — shaping how information is accessed, how clinical decisions are supported and how trust is built over time.
Our independent research with 225 senior clinicians across the UK, USA and Germany reveals a clear pattern:
Digital engagement is embedded.
Attention is selective.
Value is decisive.
The challenge is relevance.
65% say they have reduced or stopped engaging with a pharma company as a direct result of poor digital experiences. Repetitive content. Friction-filled platforms. Promotional tone. Slow access. Gated information.
This disconnect between digital activity and perceived value is what we describe as the value gap.
Across markets and specialties, three dimensions consistently determine whether digital engagement earns attention:
Relevance
Content that reflects clinical context, speciality and patient population — with greater control over what is received and when.
Utility
Digital that supports real clinical tasks: decision-making, patient conversations, access to evidence and practical resources.
Usability
Low-effort, consistent experiences that respect time and reduce friction across devices and touchpoints.
The findings also highlight a significant shift in expectations. HCPs increasingly prefer on-demand, self-directed engagement over interruptive outreach. Trust is shaped not just by the information provided, but by how clearly, transparently and efficiently it is delivered.
The path forward is not more digital.
It is more meaningful digital.
Download your copy here:
This content was provided by Graphite Digital
Company Details
Latest Content from Graphite Digital
How to successfully manage change and enable digital transformation within pharma
Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...
How Design Systems enable streamlined regulatory approval in digital pharma
The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...
Ensuring a seamless transition from design to development: Strategies for successful collaboration
When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...
Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes
Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.
How user research will help you create better digital products, whatever stage you’re at
User research provides valuable insight that will help you create better digital products and services, whatever stage you’re at.
Advancing digital engagement in pharma and healthcare: 2024 focus areas
6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users
Building trust with HCPs: 6 takeaways from our industry webinar
Key takeaways from the perspectives of industry experts across medical, commercial and digital on the issue of trust in pharma and how this impacts HCP engagement.
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
What are design systems and how can they help you elevate your digital products?
Design Systems aren’t new, but the potential to utilise them to improve the way in which teams produce digital products is still untapped for many in the pharmaceutical and healthcare...
The impact of mindset on digital product success: Download our new whitepaper
Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...